12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

PDL BioPharma management update

PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev.
Business: Antibodies

Read the full 30 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >